TX-2552 is an orally active tyrosine DNA phosphodiesterase 1 (TDP1) inhibitor with an IC50 value of 0.62 μM. TX-2552 can enhance the clastogenic activity of Topotecan in mouse bone marrow cells, as well as the anti-tumor effect of Topotecan in Krebs-2 ascites tumor mice.